Clinical Infectious Diseases

Misleading conclusion that is not in accordance with the results of the reported RCT

✅ Just Accepted
🔗 https://bit.ly/4iBZ4Pl

The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV Short-term, low-dose, semaglutide was associated with initial cardiometabolic benefit, but rapid weight regain and some loss of cardiometabolic benefit occ

The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV

✅ Just Accepted
https://bit.ly/44J1822

Implementing POCT in infectious diseases

✅ Just Accepted
🔗 https://bit.ly/4oxqjvU

Effective Antivirals in Pandemic Preparedness: Past Mistakes, Future Needs

✅ Just Accepted
🔗 https://bit.ly/3KmUhog

Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial Post-exposure doxycycline-based prophylaxis was associated with a significant increase in the frequency of N. gonorrhoeae isolates with high-level resistan

Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.

https://bit.ly/488AFNv

Screening for anal cancer is associated with real harms and questionable benefits

🔗 https://bit.ly/4qWQ9f6

A possible increase in penicillin-resistant strains of Treponema pallidum

🔗 https://bit.ly/4oQyrbH

Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice

🔗 https://bit.ly/4pmCEDJ

Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures

🔗 https://bit.ly/43K2IQZ

A Rapid Test to Differentiate Viral from Bacterial Infections: Searching for the Holy Grail

🔗 https://bit.ly/4oK7PJ6

Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data Using 2018–2024 U.S. death certificate data, 7,063 aspergillosis-attributable deaths (AAMR 2.43/1,000,000 persons) were identified, mostly invasive pulmona

Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data

✅ Just Accepted
https://bit.ly/3M4ZVM8

The latest CID supplement issue examines the IDCRC VTEU network's history, achievements, and future. Valuable insights for infectious diseases clinicians, researchers, and public health professionals. #IDSky

↪️ https://bit.ly/43lUFK4

Evaluating Personal and Environmental Decolonization Strategies for Children with Skin and Soft Tissue Infection and Their Households ? A Randomized Clinical Trial

✅ Just Accepted
🔗 https://bit.ly/48FiU7V

Surveillance of resistance-associated mutations in Treponema pallidum

✅ Just Accepted
🔗 https://bit.ly/4oQyuUV

First report of treatment-emergent resistance to cefepime-zidebactam in Pseudomonas aeruginosa

✅ Just Accepted
🔗 https://bit.ly/4oTtjDv

Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice

✅ Just Accepted
🔗 https://bit.ly/4pmCEDJ

Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures

✅ Just Accepted
🔗 https://bit.ly/43K2IQZ

Using generative artificial intelligence to identify central line-associated bloodstream infections

✅ Just Accepted
🔗 https://bit.ly/3LZD70g

IL12RB1 deficiency appearing in North America: expanding the clinical phenotypes

✅ Just Accepted
🔗 https://bit.ly/4pjYo33

Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV

✅ Just Accepted
🔗 https://bit.ly/44k3pRd

Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis

✅ Just Accepted
🔗 https://bit.ly/3K5GQsu

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023

✅ Just Accepted
🔗 https://bit.ly/4oPBYae

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023

✅ Just Accepted
🔗 https://bit.ly/4oPBYae

Home testing for contagious illness: historical context and modern caveats

✅ Just Accepted
🔗 https://bit.ly/4rlkXGG

Is Seasonal Malaria Chemoprevention with Sulfadoxine-Pyrimethamine/Amodiaquine Appropriate in East Africa?

✅ Just Accepted
🔗 https://bit.ly/3K16n67

Pharmacometric evaluation of sulfadoxine-pyrimethamine-amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda

✅ Just Accepted
🔗 https://bit.ly/44gr5pv

Artificial Intelligence and the Future of Healthcare-Associated Infection Surveillance: Bridging Precision, Partnership, Practice, and People

✅ Just Accepted
🔗 https://bit.ly/49jnzhI

Using generative AI for healthcare-associated infection surveillance Abstract. Generative artificial intelligence (GenAI) is becoming widespread in society but has had limited impact on medicine. GenAI can rapidly digest lar

Using generative AI for healthcare-associated infection surveillance

✅ Just Accepted
#IDSky

Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment?

✅ Just Accepted
🔗 https://bit.ly/489rqwy

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults

✅ Just Accepted
🔗 https://bit.ly/48aRxTS